OpenVSafe by OpenVAERS
Search V-safe

88U-13177-23403

5 vaccinations 7 coded responses 32 check-ins 6 free-text entries 2 call cases
Sex
Female
Age at first dose
66+
ZIP prefix
751 / TX
Registered
2021-02-09
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-08
    Dose 1 — Pfizer-BioNTech
  2. 2021-02-09
    Registered in v-safe
  3. 2021-02-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-02-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-02-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-02-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-02-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-02-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-02-15
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-02-22
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-03-01
    Dose 2 — Pfizer-BioNTech
  12. 2021-03-01
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-03-02
    Survey response — days 1–6 daily, dose 2
    MedDRA: Eye pain, Photophobia — Feeling: Poor · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Eyes hurt, light sensitivity
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-03-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  15. 2021-03-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  16. 2021-03-05
    Survey response — days 1–6 daily, dose 2
    MedDRA: Photophobia — Feeling: Fair · Headache
    Free text: Sensitivity to light
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-03-06
    Survey response — days 1–6 daily, dose 2
    MedDRA: Photophobia — Feeling: Good · Fatigue or tiredness
    Free text: Sensitivity to light
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-03-07
    Survey response — days 1–6 daily, dose 2
    MedDRA: Depression — Feeling: Good
    Free text: The third and fourth day following the vaccination, I was very depressed.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-03-08
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-03-15
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-03-22
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-29
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-04-05
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-04-12
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-05-31
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-09-01
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-11-10
    Dose 3 — Pfizer-BioNTech
  28. 2022-04-22
    Dose 4 — Pfizer-BioNTech
  29. 2022-09-29
    Dose 5 — Pfizer-BioNTech
  30. 2022-10-04
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  31. 2022-10-05
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  32. 2022-10-06
    Health check-in — day 7, dose 5
    Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  33. 2022-10-13
    Health check-in — day 14, dose 5
    Feeling: Fair
    Adult check-in
  34. 2022-10-20
    Health check-in — day 21, dose 5
    Feeling: Good
    Adult check-in
  35. 2022-10-27
    Health check-in — day 28, dose 5
    Feeling: Fair
    Adult check-in
  36. 2022-11-03
    Survey response — day 35, dose 5
    MedDRA: Surgery, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization
    Free text: Symptoms: Biopsy of right temporal artery in effort to diagnose giant cell arteritis. Biopsy was negative. · Healthcare visit (other): Day surgery
    MedDRA releases: 2024-11 · check-in free text available
  37. 2022-11-03
    Report sent to call center — day 35, dose 5
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Hospitalization · 1 call case(s)
  38. 2022-11-04
  39. 2022-11-10
    Survey response — day 42, dose 5
    MedDRA: Mobility decreased, Polymyalgia rheumatica, Red blood cell sedimentation rate increased — Feeling: Good
    Free text: Diagnosis: poly myalgia rheumatica Had right temporal artery biopsy for giant cell arteritis, negative. 10/28 /20. Treatment: prednisone or hydroxychlorophine ESR chronically high, restricted mobility. Health records complete, No COVID.
    MedDRA releases: 2024-11 · check-in free text available
  40. 2023-03-30
    Survey response — 6 months, dose 5
    MedDRA: Bronchitis, Office visit, Pyrexia — Feeling: Fair · Get care from a doctor or other healthcare professional
    MedDRA releases: 2024-11
  41. 2023-03-30
    Report sent to call center — 6 months, dose 5
    Get care from a doctor or other healthcare professional
    1 call case(s)
  42. 2023-03-31
  43. 2023-03-31

Vaccinations

DoseDateManufacturerCo-administered
12021-02-08Pfizer-BioNTech
22021-03-01Pfizer-BioNTech
32021-11-10Pfizer-BioNTech No
42022-04-22Pfizer-BioNTech No
52022-09-29Pfizer-BioNTech No

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 4 — days 1–6 daily, dose 2

2021-03-02

Systemic reaction (other): Eyes hurt, light sensitivity

Release 5 — days 1–6 daily, dose 2

2021-03-05

Systemic reaction (other): Sensitivity to light

2021-03-06

Systemic reaction (other): Sensitivity to light

2021-03-07

Systemic reaction (other): The third and fourth day following the vaccination, I was very depressed.

Release 12 — day 35, dose 5

2022-11-03

Symptoms: Biopsy of right temporal artery in effort to diagnose giant cell arteritis. Biopsy was negative.
Healthcare visit (other): Day surgery

Release 12 — day 42, dose 5

2022-11-10

Symptoms: Diagnosis: poly myalgia rheumatica Had right temporal artery biopsy for giant cell arteritis, negative. 10/28 /20. Treatment: prednisone or hydroxychlorophine ESR chronically high, restricted mobility. Health records complete, No COVID.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
HCVOSurgery · · ✓
SDBronchitis · · ✓
SDMobility decreased · · ✓
SDPolymyalgia rheumatica · · ✓
SDPyrexia · · ✓
SDRed blood cell sedimentation rate increased · · ✓
SDUnevaluable event · · ✓
SRODepression ✓ ✓ ✓
SROEye pain ✓ ✓ ✓
SROPhotophobia ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release